ANNOUNCEMENT: December Record Sales

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

7 January 2021

Sativa Wellness Group Inc.
(“Sativa Wellness” or the “Company”)

December Record Sales

We are pleased to advise that December 2020 was another record sales month for Sativa Wellness Group.

2020 was a transformational year for the company as we combined with Stillcanna Inc. to create a leading European seed to consumer company in the CBD wellness market. Having a fully integrated supply chain allows us to control both quality and costs. Producing a traceable high-quality product has never been more important than today as we approach the UK FSA Novel Food validation deadline at the end of March. Sativa is well prepared for this process and embraces a market with high quality, compliant products.

In 2021 our sights are on continuing to drive sales in the UK and truly extending our reach into Europe. We already have a strong presence in Europe with our extraction and production plant, and we are now extending our capabilities to sell and distribute our products in European markets.

All the best for a safe, healthy, happy and prosperous 2021.

Kind regards
Henry Lees-Buckley

The Directors of the Company accept responsibility for the contents of this announcement.

On behalf of the Board of Directors,

Henry Lees-Buckley
Chief Executive Officer
Sativa Group Plc
+44 (0) 20 7971 1255
[email protected]
www.sativawellnessgroup.com

Joseph Colliver
Chief Financial Officer
Sativa Group Plc
+44 (0) 20 7971 1255
[email protected]
www.sativawellnessgroup.com

Jason Dussault
Investor Relations and Communications
Sativa Wellness Group Inc. (formerly Stillcanna Inc.)
[email protected]
www.sativawellnessgroup.com

AQSE Growth Market Corporate Advisor
Corporate Finance
Guy Miller/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7220 9795
[email protected]

Share on

Share on linkedin
Share on twitter
Share on facebook
Share on email

Published on

Categories